Generation and Characterization of Polyclonal Antibodies Specific for Human p110 sEGFR
- 1 June 2002
- journal article
- research article
- Published by Mary Ann Liebert Inc in Hybridoma and Hybridomics
- Vol. 21 (3), 183-189
- https://doi.org/10.1089/153685902760173908
Abstract
The EGFR/ERBB family of receptor tyrosine kinases mediates intracellular signal transduction pathways important in the regulation of cell growth, differentiation, and transformation. We previously have reported the cloning and expression of a 3 kb alternative EGFR transcript which encodes a 110 kDa form of the receptor (p110 sEGFR). This receptor isoform is identical to the extracellular region of the full-length 170 kDa EGFR through amino acid 603; in addition, p110 sEGFR contains 78 unique carboxy-terminal amino acids. Here, we report the generation and characterization of polyclonal antisera specific for the unique carboxy-terminal sequence of p110 sEGFR. Polyclonal antisera were generated by immunizing rabbits with synthetic peptides corresponding to peptides contained within the unique carboxy-terminal sequence of p110 sEGFR. Immunoglobulin fractions from antisera which tested positive for immune reactivity to these peptides by ELISA were affinity-purified by protein G and peptide-based chromatography. This affinity-purified immunoglobulin fraction specifically recognizes p110 sEGFR by ELISA, immunoprecipitation, immunoblot analysis, and immunocytochemical methods. No cross-reactivity with full-length p170 EGFR is observed using any of these detection methods. These new polyclonal antibodies will be useful in determining the expression, localization, and function of p110 sEGFR, and importantly will allow us to distinguish between the expression of this receptor isoform and p170 EGFR.Keywords
This publication has 12 references indexed in Scilit:
- Comparative Genomic Sequence Analysis and Isolation of Human and Mouse Alternative EGFR Transcripts Encoding Truncated Receptor IsoformsGenomics, 2000
- The EGF receptor family as targets for cancer therapyOncogene, 2000
- Targeting of epidermal growth factor receptor and protein kinase A: Molecular basis and therapeutic applicationsPublished by Elsevier BV ,2000
- The Epidermal Growth Factor Receptor and Its Inhibition in Cancer TherapyPharmacology & Therapeutics, 1999
- A sandwich type Acridinium-Linked ImmunoSorbent Assay (ALISA) detects soluble ErbB1 (sErbB1) in normal human seraJournal of Immunological Methods, 1998
- Monoclonal Antibodies Specific for Peptide Epitopes of the Epidermal Growth Factor Receptor's Extracellular DomainHybridoma, 1997
- A 1.8 kb alternative transcript from the human epidermal growth factor receptor gene encodes a truncated form of the receptorNucleic Acids Research, 1996
- Epidermal growth factor-related peptides and their receptors in human malignanciesCritical Reviews in Oncology/Hematology, 1995
- Proviral insertional activation of c-erbB: differential processing of the protein products arising from two alternate transcripts.Molecular and Cellular Biology, 1988
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970